The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.
wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Michael G. Shlipak

Department of Medicine

University of California

San Francisco

California 94121

USA

[email]@*.ucsf.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, University of California, San Francisco, California 94121, USA. 2000 - 2007
  • General Internal Medicine Section, Veterans Affairs Medical Center, and Department of Medicine, University of California, USA. 2000 - 2005
  • Epidemiology and Biostatistics, University of California, San Francisco, General Internal Medicine Section, USA. 2004

References

  1. Cystatin C as a marker of glomerular filtration rate in chronic kidney disease: influence of body composition. Shlipak, M.G. Nature Clinical Practice. Nephrology (2007) [Pubmed]
  2. Update on cystatin C: new insights into the importance of mild kidney dysfunction. Shlipak, M.G., Praught, M.L., Sarnak, M.J. Curr. Opin. Nephrol. Hypertens. (2006) [Pubmed]
  3. Cystatin-C and mortality in elderly persons with heart failure. Shlipak, M.G., Katz, R., Fried, L.F., Jenny, N.S., Stehman-Breen, C.O., Newman, A.B., Siscovick, D., Psaty, B.M., Sarnak, M.J. J. Am. Coll. Cardiol. (2005) [Pubmed]
  4. Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. Shlipak, M.G., Fried, L.F., Cushman, M., Manolio, T.A., Peterson, D., Stehman-Breen, C., Bleyer, A., Newman, A., Siscovick, D., Psaty, B. JAMA (2005) [Pubmed]
  5. Cystatin C and the risk of death and cardiovascular events among elderly persons. Shlipak, M.G., Sarnak, M.J., Katz, R., Fried, L.F., Seliger, S.L., Newman, A.B., Siscovick, D.S., Stehman-Breen, C. N. Engl. J. Med. (2005) [Pubmed]
  6. Cystatin-C and inflammatory markers in the ambulatory elderly. Shlipak, M.G., Katz, R., Cushman, M., Sarnak, M.J., Stehman-Breen, C., Psaty, B.M., Siscovick, D., Tracy, R.P., Newman, A., Fried, L. Am. J. Med. (2005) [Pubmed]
  7. Creatinine levels and cardiovascular events in women with heart disease: do small changes matter?. Shlipak, M.G., Stehman-Breen, C., Vittinghoff, E., Lin, F., Varosy, P.D., Wenger, N.K., Furberg, C.D. Am. J. Kidney Dis. (2004) [Pubmed]
  8. Chronic renal insufficiency and cardiovascular events in the elderly: findings from the Cardiovascular Health Study. Shlipak, M.G., Fried, L.F., Stehman-Breen, C., Siscovick, D., Newman, A.B. Am. J. Geriatr. Cardiol (2004) [Pubmed]
  9. The presence of frailty in elderly persons with chronic renal insufficiency. Shlipak, M.G., Stehman-Breen, C., Fried, L.F., Song, X., Siscovick, D., Fried, L.P., Psaty, B.M., Newman, A.B. Am. J. Kidney Dis. (2004) [Pubmed]
  10. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. Shlipak, M.G., Smith, G.L., Rathore, S.S., Massie, B.M., Krumholz, H.M. J. Am. Soc. Nephrol. (2004) [Pubmed]
  11. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Shlipak, M.G., Fried, L.F., Crump, C., Bleyer, A.J., Manolio, T.A., Tracy, R.P., Furberg, C.D., Psaty, B.M. Circulation (2003) [Pubmed]
  12. Pharmacotherapy for heart failure in patients with renal insufficiency. Shlipak, M.G. Ann. Intern. Med. (2003) [Pubmed]
  13. Lipid changes on hormone therapy and coronary heart disease events in the Heart and Estrogen/progestin Replacement Study (HERS). Shlipak, M.G., Chaput, L.A., Vittinghoff, E., Lin, F., Bittner, V., Knopp, R.H., Hulley, S.B. Am. Heart J. (2003) [Pubmed]
  14. Cardiovascular disease risk status in elderly persons with renal insufficiency. Shlipak, M.G., Fried, L.F., Crump, C., Bleyer, A.J., Manolio, T.A., Tracy, R.P., Furberg, C.D., Psaty, B.M. Kidney Int. (2002) [Pubmed]
  15. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Shlipak, M.G., Heidenreich, P.A., Noguchi, H., Chertow, G.M., Browner, W.S., McClellan, M.B. Ann. Intern. Med. (2002) [Pubmed]
  16. The incidence of unrecognized myocardial infarction in women with coronary heart disease. Shlipak, M.G., Elmouchi, D.A., Herrington, D.M., Lin, F., Grady, D., Hlatky, M.A. Ann. Intern. Med. (2001) [Pubmed]
  17. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. Shlipak, M.G., Simon, J.A., Grady, D., Lin, F., Wenger, N.K., Furberg, C.D. J. Am. Coll. Cardiol. (2001) [Pubmed]
  18. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause. Shlipak, M.G., Simon, J.A., Vittinghoff, E., Lin, F., Barrett-Connor, E., Knopp, R.H., Levy, R.I., Hulley, S.B. JAMA (2000) [Pubmed]
  19. Clinical symptoms and myocardial infarction in left bundle branch block patients. Shlipak, M.G., Go, A.S., Lyons, W.L., Browner, W.S. Cardiology (2000) [Pubmed]
  20. Treatment and outcomes of left bundle-branch block patients with myocardial infarction who present without chest pain. National Registry of Myocardial Infarction 2 Investigators. Shlipak, M.G., Go, A.S., Frederick, P.D., Malmgren, J., Barron, H.V., Canto, J.G. J. Am. Coll. Cardiol. (2000) [Pubmed]
 
WikiGenes - Universities